Milestone Scientific, Inc. · AMEX:MLSS
Milestone Scientific — Investor Presentation (October 2021)
14 slides from Milestone Scientific's investor presentation, October 2021
Slide 1: Investor Presentation October 2021
Investor Presentation October 2021 NYSE: MLSS 1
Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues, timing of regulatory approvals and future success. These statements involve a number of risks and uncertaint
Slide 3: Executive Summary
Executive Summary ¡ Milestone Scientific Inc. (MLSS) is a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections. ¡ MLSS has now entered into a significant expansion in the world-wide dental market. ¡ Based on MLSS fundamental technology o
Slide 4: Company History
Company History Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. With 133 foreign patents and 19 US pate
Slide 5: Why Enter the Epidural Market?
Why Enter the Epidural Market? Market Size Epidural procedures are one of the fastest growing procedures in the US and worldwide. It is estimated that over 11 million epidural procedures are performed each year in the US and over 30 million worldwide. Over $5 billion is spent annually on epidural in
Slide 6: Current Technology Being Used Today!
Current Technology Being Used Today! The technique of "single-shot" lumbar epidural anesthesia was first developed in 1921 by Spanish military surgeon Fidel Pagés, and hasn’t changed significantly since. Glass Loss of Resistance “Modern” LOR (LOR) 1946 Syringes 6
Slide 7: Listening to Providers, Addressing Unmet Needs
Listening to Providers, Addressing Unmet Needs § Placement of an epidural needle is difficult; Requiring 60-90 placements before reaching an adequate skill level § 17% of failure rates are due to false loss of resistance (False Loss of resistance is when the needle enters soft tissue or fatty tissue
Slide 8: Cost Savings of More Than $500 Per Hospital Stay on Average
Cost Savings of More Than $500 Per Hospital Stay on Average ¡ Department of Anesthesiology, University of Texas Medical Branch at Galveston ¡ Objective: Cost effectiveness analysis of CompuFlo with real-time pressure sensing technology and traditional LOR technique in parturients requesting labor ep
Slide 9: Innovating a New Standard of Care in Anesthesia
Innovating a New Standard of Care in Anesthesia • Now with our patented CompuWave™ and CathCheck™ features, anesthesiologists should be able to save significant time and institutions should save significant costs • Correlates subjective feel with objective visual and audible verification of pressure
Slide 10: Two New Features added to the CompuFlo Epidural Instrument
Two New Features added to the CompuFlo Epidural Instrument With the addition of the patented CompuWave™ technology we can now not only verify epidural placement but also confirm catheter placement in real time with the patients’ pulse 22
Slide 11: What Do These New Features Mean?
What Do These New Features Mean? Until now clinicians check catheters by administering a bolus of anesthetic to a patient and are then required to wait 20-40 minutes to see if patient’s pain has subsided, if it doesn’t the catheter has to be removed and another epidural must be performed. With CathC
Slide 12: Milestone Scientific- Market Re-Cap
Milestone Scientific- Market Re-Cap Epidural is one of the fastest growing segments in Medicine § 11 million performed in the US and 30 million worldwide § 2.4 million Labor and Delivery-US § 9 million nerve blocks for pain intervention-US § 900,000+ for pain blocks in Hips and Knees- US § Over a $5
Slide 13: Beyond Epidural: The Medical Opportunity
Beyond Epidural: The Medical Opportunity Catheter ü Now with our patented CompuWave™ technology the Check CompuFlo Epidural Instrument can now check catheters in 1-2 minutes not 20-40 minutes. Thoracic ü High-risk nature of procedure; 3 – 5 % of all epidurals, Study currently underway. Peripheral ü
Slide 14: Thank You!
MILEST&3NE SCITENTIFIC® milestonescientific.com Thank You! NYSE: MLSS
Milestone Scientific — Investor Presentation (October 2021) on 6ix